0 0 0 0.00899318191324701 0.0121721671476972 0.00702723051825822 0.0153929811352323 0.00294892709248337
Sign Up Today X
Thanks for submitting the form.
Stockreport

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields [Yahoo! Finance]

MiMedx Group, Inc (MDXG)  More Company Research Source: Yahoo! Finance
Last mimedx group, inc earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension of the Company's AMNIOFIX dehydrated human amnion/chorion membrane (DHACM) allografts. AMNIOFIX Thyroid Shields are allografts designed and intended for use in endocrine surgery. Following a thyroidectomy, the sheets—provided in preconfigured sizes—are applied to the exposed Recurrent Laryngeal Nerve (RLN) and parathyroid glands to provide a protective barrier and thereby support the healing cascade. The product is designed to prevent the need for intraoperative modification, saving valuable time in the operating room. AMNIOFIX Thyroid Shields are manufactured by MIMEDX using the PURION ® process, are easy to apply, and are shelf-stable for up to five years. “Injuries to the recurrent laryngeal nerve are a great concern during thyroid and parathyroid operations, particularly as d [Read more]
IMPACT SNAPSHOT EVENT TIME: MDXG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
MDXG alerts
from News Quantified
MDXG
NEWS
MDXG
Earnings
MDXG
Analyst Actions
MDXG
SEC Filings
Stockreport

MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields [Yahoo! Finance]

MiMedx Group, Inc  (MDXG) 
More Company Research Source: Yahoo! Finance
Last mimedx group, inc earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml?c=213465&p=irol-irhome
MARIETTA, Ga., March 05, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the commercial launch of AMNIOFIX Thyroid Shields, a product line extension of the Company's AMNIOFIX dehydrated human amnion/chorion membrane (DHACM) allografts. AMNIOFIX Thyroid Shields are allografts designed and intended for use in endocrine surgery. Following a thyroidectomy, the sheets—provided in preconfigured sizes—are applied to the exposed Recurrent Laryngeal Nerve (RLN) and parathyroid glands to provide a protective barrier and thereby support the healing cascade. The product is designed to prevent the need for intraoperative modification, saving valuable time in the operating room. AMNIOFIX Thyroid Shields are manufactured by MIMEDX using the PURION ® process, are easy to apply, and are shelf-stable for up to five years. “Injuries to the recurrent laryngeal nerve are a great concern during thyroid and parathyroid operations, particularly as d [Read more]
IMPACT SNAPSHOT
EVENT TIME:
MDXG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS